Cohen S M, Flynn H W, Murray T G, Smiddy W E
Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami School of Medicine, FL, USA.
Ophthalmology. 1995 May;102(5):705-12. doi: 10.1016/s0161-6420(95)30965-7.
To describe the clinical course and incidence of culture-proven postvitrectomy endophthalmitis in 18 patients from five academic centers and three private practices.
Patients undergoing pars plana vitrectomy for recent trauma or endophthalmitis were excluded. The average age was 58 years (range, 21-85 year). Sixty-one percent of the patients (11/18) had diabetes mellitus. The indication for initial vitrectomy was vitreous hemorrhage (n = 10), macular epiretinal membrane (n = 3), recurrent retinal detachment with proliferative vitreoretinopathy (n = 2), retinal detachment with retinoschisis (n = 1), proliferative diabetic retinopathy with tractional retinal detachment (n = 1), and dislocated intraocular lens (n = 1). None of these eyes received prophylactic intraocular antibiotics during the vitrectomy.
All eyes were treated with intraocular antibiotics after the diagnosis of postvitrectomy endophthalmitis was made. Final visual acuity ranged from 20/20 to no light perception and included five eyes with 20/50 or better visual acuity and 11 eyes with less than 5/200 visual acuity. Nine eyes had a final visual acuity of no light perception. Of the 16 eyes infected with a single organism, 71% (5/7) of eyes infected with coagulase-negative staphylococci retained 20/50 or better final visual acuity compared with no eyes (0/9) infected with other organisms (P = 0.005). Two eyes infected with both coagulase-negative Staphylococcus and Streptococcus had a final visual acuity of 20/400. Three eyes with a total hypopyon later had enucleation or evisceration. Based on the data from four medical centers, the incidence of endophthalmitis after pars plana vitrectomy performed over the last 10 years was 9/12,216 (0.07%).
Endophthalmitis after vitrectomy is rare. Postvitrectomy bacterial endophthalmitis caused by organisms other than coagulase-negative staphylococci has a poor visual prognosis.
描述来自五个学术中心和三个私人诊所的18例患者经培养证实的玻璃体切除术后眼内炎的临床病程及发生率。
排除因近期外伤或眼内炎而接受玻璃体切除术的患者。平均年龄为58岁(范围21 - 85岁)。61%的患者(11/18)患有糖尿病。初次玻璃体切除术的指征为玻璃体积血(n = 10)、黄斑视网膜前膜(n = 3)、伴有增殖性玻璃体视网膜病变的复发性视网膜脱离(n = 2)、伴有视网膜劈裂的视网膜脱离(n = 1)、伴有牵引性视网膜脱离的增殖性糖尿病视网膜病变(n = 1)以及人工晶状体脱位(n = 1)。这些眼中无一在玻璃体切除术中接受预防性眼内抗生素治疗。
在诊断为玻璃体切除术后眼内炎后,所有眼均接受了眼内抗生素治疗。最终视力范围从20/20到无光感,其中5只眼视力为20/50或更好,11只眼视力低于5/200。9只眼最终视力为无光感。在16只感染单一病原体的眼中,感染凝固酶阴性葡萄球菌的眼有71%(5/7)最终视力保持在20/50或更好,而感染其他病原体的眼无一如此(0/9)(P = 0.005)。两只同时感染凝固酶阴性葡萄球菌和链球菌的眼最终视力为20/400。三只全前房积脓的眼后来进行了眼球摘除或眼内容剜出术。根据四个医疗中心的数据,过去10年中玻璃体切除术后眼内炎的发生率为9/12,216(0.07%)。
玻璃体切除术后眼内炎罕见。由凝固酶阴性葡萄球菌以外的病原体引起的玻璃体切除术后细菌性眼内炎视力预后较差。